These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32580974)

  • 1. Sex-driven modifiers of Alzheimer risk: A multimodality brain imaging study.
    Rahman A; Schelbaum E; Hoffman K; Diaz I; Hristov H; Andrews R; Jett S; Jackson H; Lee A; Sarva H; Pahlajani S; Matthews D; Dyke J; de Leon MJ; Isaacson RS; Brinton RD; Mosconi L
    Neurology; 2020 Jul; 95(2):e166-e178. PubMed ID: 32580974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sex differences in Alzheimer risk: Brain imaging of endocrine vs chronologic aging.
    Mosconi L; Berti V; Quinn C; McHugh P; Petrongolo G; Varsavsky I; Osorio RS; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Brinton RD
    Neurology; 2017 Sep; 89(13):1382-1390. PubMed ID: 28855400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parallel ICA of FDG-PET and PiB-PET in three conditions with underlying Alzheimer's pathology.
    Laforce R; Tosun D; Ghosh P; Lehmann M; Madison CM; Weiner MW; Miller BL; Jagust WJ; Rabinovici GD
    Neuroimage Clin; 2014; 4():508-16. PubMed ID: 24818077
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitative longitudinal interrelationships between brain metabolism and amyloid deposition during a 2-year follow-up in patients with early Alzheimer's disease.
    Förster S; Yousefi BH; Wester HJ; Klupp E; Rominger A; Förstl H; Kurz A; Grimmer T; Drzezga A
    Eur J Nucl Med Mol Imaging; 2012 Dec; 39(12):1927-36. PubMed ID: 22926714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Alzheimer's risk during the menopause transition: A 3-year longitudinal brain imaging study.
    Mosconi L; Rahman A; Diaz I; Wu X; Scheyer O; Hristov HW; Vallabhajosula S; Isaacson RS; de Leon MJ; Brinton RD
    PLoS One; 2018; 13(12):e0207885. PubMed ID: 30540774
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of amyloid β on cognitive decline is modulated by neural integrity in cognitively normal elderly.
    Wirth M; Oh H; Mormino EC; Markley C; Landau SM; Jagust WJ
    Alzheimers Dement; 2013 Nov; 9(6):687-698.e1. PubMed ID: 23474040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutrient intake and brain biomarkers of Alzheimer's disease in at-risk cognitively normal individuals: a cross-sectional neuroimaging pilot study.
    Mosconi L; Murray J; Davies M; Williams S; Pirraglia E; Spector N; Tsui WH; Li Y; Butler T; Osorio RS; Glodzik L; Vallabhajosula S; McHugh P; Marmar CR; de Leon MJ
    BMJ Open; 2014 Jun; 4(6):e004850. PubMed ID: 24961717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Associations between Alzheimer disease biomarkers, neurodegeneration, and cognition in cognitively normal older people.
    Wirth M; Villeneuve S; Haase CM; Madison CM; Oh H; Landau SM; Rabinovici GD; Jagust WJ
    JAMA Neurol; 2013 Dec; 70(12):1512-9. PubMed ID: 24166579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer Disease Signature Neurodegeneration and APOE Genotype in Mild Cognitive Impairment With Suspected Non-Alzheimer Disease Pathophysiology.
    Schreiber S; Schreiber F; Lockhart SN; Horng A; Bejanin A; Landau SM; Jagust WJ;
    JAMA Neurol; 2017 Jun; 74(6):650-659. PubMed ID: 28319241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Age and neurodegeneration imaging biomarkers in persons with Alzheimer disease dementia.
    Knopman DS; Jack CR; Wiste HJ; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Machulda MM; Roberts RO; Boeve BF; Jones DT; Petersen RC
    Neurology; 2016 Aug; 87(7):691-8. PubMed ID: 27421543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mediterranean diet and 3-year Alzheimer brain biomarker changes in middle-aged adults.
    Berti V; Walters M; Sterling J; Quinn CG; Logue M; Andrews R; Matthews DC; Osorio RS; Pupi A; Vallabhajosula S; Isaacson RS; de Leon MJ; Mosconi L
    Neurology; 2018 May; 90(20):e1789-e1798. PubMed ID: 29653991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of neuroimaging modalities for the prediction of conversion from mild cognitive impairment to Alzheimer's dementia.
    Trzepacz PT; Yu P; Sun J; Schuh K; Case M; Witte MM; Hochstetler H; Hake A;
    Neurobiol Aging; 2014 Jan; 35(1):143-51. PubMed ID: 23954175
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-specific population frequencies of cerebral β-amyloidosis and neurodegeneration among people with normal cognitive function aged 50-89 years: a cross-sectional study.
    Jack CR; Wiste HJ; Weigand SD; Rocca WA; Knopman DS; Mielke MM; Lowe VJ; Senjem ML; Gunter JL; Preboske GM; Pankratz VS; Vemuri P; Petersen RC
    Lancet Neurol; 2014 Oct; 13(10):997-1005. PubMed ID: 25201514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 18F-fluorodeoxyglucose positron emission tomography, aging, and apolipoprotein E genotype in cognitively normal persons.
    Knopman DS; Jack CR; Wiste HJ; Lundt ES; Weigand SD; Vemuri P; Lowe VJ; Kantarci K; Gunter JL; Senjem ML; Mielke MM; Roberts RO; Boeve BF; Petersen RC
    Neurobiol Aging; 2014 Sep; 35(9):2096-106. PubMed ID: 24702820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Amyloid burden and metabolic function in early-onset Alzheimer's disease: parietal lobe involvement.
    Ossenkoppele R; Zwan MD; Tolboom N; van Assema DM; Adriaanse SF; Kloet RW; Boellaard R; Windhorst AD; Barkhof F; Lammertsma AA; Scheltens P; van der Flier WM; van Berckel BN
    Brain; 2012 Jul; 135(Pt 7):2115-25. PubMed ID: 22556189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alzheimer's disease neurodegenerative biomarkers are associated with decreased cognitive function but not β-amyloid in cognitively normal older individuals.
    Wirth M; Madison CM; Rabinovici GD; Oh H; Landau SM; Jagust WJ
    J Neurosci; 2013 Mar; 33(13):5553-63. PubMed ID: 23536070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting Imminent Progression to Clinically Significant Memory Decline Using Volumetric MRI and FDG PET.
    Stonnington CM; Chen Y; Savage CR; Lee W; Bauer RJ; Sharieff S; Thiyyagura P; Alexander GE; Caselli RJ; Locke DEC; Reiman EM; Chen K
    J Alzheimers Dis; 2018; 63(2):603-615. PubMed ID: 29630550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nutrient patterns and brain biomarkers of Alzheimer's disease in cognitively normal individuals.
    Berti V; Murray J; Davies M; Spector N; Tsui WH; Li Y; Williams S; Pirraglia E; Vallabhajosula S; McHugh P; Pupi A; de Leon MJ; Mosconi L
    J Nutr Health Aging; 2015 Apr; 19(4):413-23. PubMed ID: 25809805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations of lifestyle and vascular risk factors with Alzheimer's brain biomarker changes during middle age: a 3-year longitudinal study in the broader New York City area.
    Walters MJ; Sterling J; Quinn C; Ganzer C; Osorio RS; Andrews RD; Matthews DC; Vallabhajosula S; de Leon MJ; Isaacson RS; Mosconi L
    BMJ Open; 2018 Nov; 8(11):e023664. PubMed ID: 30478117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early 11C-PIB frames and 18F-FDG PET measures are comparable: a study validated in a cohort of AD and FTLD patients.
    Rostomian AH; Madison C; Rabinovici GD; Jagust WJ
    J Nucl Med; 2011 Feb; 52(2):173-9. PubMed ID: 21233181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.